NDC 50242-159

Lunsumio

Mosunetuzumab

Lunsumio is a Intravenous Concentrate in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Mosunetuzumab.

• Product ID: 50242-159_3c8d2a27-5057-4c5a-b9fc-c6d67afdd2f7
• NDC: 50242-159
• Product Type: Human Prescription Drug
• Proprietary Name: Lunsumio
• Generic Name: Mosunetuzumab
• Dosage Form: Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-12-22
• Marketing Category: BLA /
• Application Number: BLA761263
• Labeler Name: Genentech, Inc.
• Substance Name: MOSUNETUZUMAB
• Active Ingredient Strength: 1 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50242-159-01

1 VIAL in 1 CARTON (50242-159-01) > 1 mL in 1 VIAL

• Marketing Start Date: 2022-12-22
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Lunsumio" or generic name "Mosunetuzumab"

NDC	Brand Name	Generic Name
50242-142	Lunsumio	Mosunetuzumab
50242-159	Lunsumio	Mosunetuzumab